Baltruškevičienė, Edita, Ugnius Mickys, Tadas Žvirblis, Rokas Stulpinas, Teresė Pipirienė Želvienė, and Eduardas Aleknavičius. “Significance of KRAS, NRAS, BRAF and PIK3CA Mutations in Metastatic Colorectal Cancer Patients Receiving Bevacizumab: A single Institution Experience”. Acta medica Lituanica 23, no. 1 (April 7, 2016): 24–34. Accessed May 7, 2024. https://www.journals.vu.lt/AML/article/view/21456.